Alpha 2.0
Login Register
» Authors » Etienne Cramer

Etienne Cramer

Explore the profile of Etienne Cramer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 51
Followers 0
Related Specialties
Cardiology & Vascular Diseases
General Medicine
Top 10 Co-Authors
Eelko Ronner
Anho Liem
Arthur Maas
K Martijn Akkerhuis
Rohit M Oemrawsingh
Folkert W Asselbergs
Carl Schotborgh
Eric Boersma
Alexander J Wardeh
Pim van der Harst
Published In
BMJ Open
Arch Cardiol Mex
Am J Cardiol
J Am Heart Assoc
Circulation
Affiliations
Soon will be listed here.
Recent Articles
1.
Rapid Improvements in Physical Activity and Sedentary Behavior in Patients With Acute Myocardial Infarction Immediately Following Hospital Discharge
van Bakel B, de Koning I, Bakker E, Pop G, Cramer E, van Geuns R, et al.
J Am Heart Assoc . 2023 May; 12(10):e028700. PMID: 37158085
Background Little is known about changes in physical activity (PA) and sedentary behavior (SB) patterns in the acute phase of a myocardial infarction (MI). We objectively assessed PA and SB...
2.
Acute rule-out of non-ST-segment elevation acute coronary syndrome in the (pre)hospital setting by HEART score assessment and a single point-of-care troponin: rationale and design of the ARTICA randomised trial
Aarts G, Camaro C, van Geuns R, Cramer E, Van Kimmenade R, Damman P, et al.
BMJ Open . 2020 Feb; 10(2):e034403. PMID: 32071186
Introduction: Because of the lack of prehospital protocols to rule out a non-ST-segment elevation acute coronary syndrome (NSTE-ACS), patients with chest pain are often transferred to the emergency department (ED)...
3.
Temporal Pattern of Growth Differentiation Factor-15 Protein After Acute Coronary Syndrome (From the BIOMArCS Study)
Buljubasic N, Vroegindewey M, Oemrawsingh R, Asselbergs F, Cramer E, Liem A, et al.
Am J Cardiol . 2019 May; 124(1):8-13. PMID: 31047655
Growth differentiation factor-15 (GDF-15) has appeared as a promising biomarker with strong predictive abilities in acute coronary syndrome (ACS). However, studies are solely based on single measurements in the acute...
4.
High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary Syndrome
Oemrawsingh R, Akkerhuis K, Mulder M, Umans V, Kietselaer B, Schotborgh C, et al.
Circulation . 2018 Dec; 139(1):134-136. PMID: 30592652
No abstract available.
5.
Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome-a prospective multicentre biomarker study conducted in the Netherlands
Oemrawsingh R, Akkerhuis K, Umans V, Kietselaer B, Schotborgh C, Ronner E, et al.
BMJ Open . 2016 Dec; 6(12):e012929. PMID: 28011810
Purpose: Progression of stable coronary artery disease (CAD) towards acute coronary syndrome (ACS) is a dynamic and heterogeneous process with many intertwined constituents, in which a plaque destabilising sequence could...
6.
Troponin I release at rest and after exercise in patients with hypertrophic cardiomyopathy and the effect of betablockade
Pop G, Cramer E, Timmermans J, Bos H, Verheugt F
Arch Cardiol Mex . 2007 Feb; 76(4):415-8. PMID: 17315619
Purpose Of The Work: In patients with hypertrophic cardiomyopathy ischemia may occur due to massive heart weight, myocyte disarray or small vessel disease. We detected elevated troponin levels in some...